November 12, 2019 / 6:26 AM / a month ago

BRIEF-Novartis cites positive data for Cosentyx in axial spondyloarthritis

Nov 12 (Reuters) - Novartis AG:

* NEW NOVARTIS PREVENT DATA SHOW COSENTYX DELIVERS EARLY RELIEF IN AXIAL SPONDYLOARTHRITIS

* 42.2% OF PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS (NR-AXSPA) TREATED WITH COSENTYX HAD IMPROVED ASAS40 SCORES THROUGH WEEK 16; IMPROVEMENTS CONTINUED THROUGH WEEK 52 Source text for Eikon: Further company coverage: (Reporting By Michael Shields)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below